Esbjerg Hospital - University Hospital of Southern Denmark clinical trial pipeline

4 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 4 with minor changes only.

1. Minor

   Non-pharmacological Treatment of Patients at Risk of Developing…Non-pharmacological Treatment of Patients at Risk of Developing Persistent Post-traumatic Headache: The PTHEENOT Study

   Completed without a posted recruiting period

   Also in this update: Primary completion date changed from estimate of May 1, 2026 to Mar 24, 2026

   Esbjerg Hospital - University Hospital of Southern Denmark·Not applicable· NCT06466499· Registry history of NCT06466499 on ClinicalTrials.gov (opens the registry)

   Oct 7, 2026

2. Minor

   GINEBRA · Glucose-dependent INsulinotropic Polypeptide: Effect on…GINEBRA · Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)

   Trial completed

   Also in this update: Primary completion date changed from estimate of Nov 1, 2026 to Sep 17, 2026

   Esbjerg Hospital - University Hospital of Southern Denmark·Not applicable· NCT06790225· Registry history of NCT06790225 on ClinicalTrials.gov (opens the registry)

   Oct 1, 2026

3. Minor

   Cryoneurolysis Prior to Total Knee Arthroplasty

   Study completion pushed from Mar 1, 2026 to Dec 31, 2026

   Esbjerg Hospital - University Hospital of Southern Denmark·Not applicable· NCT05840276· Registry history of NCT05840276 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

4. Minor

   Weight-Neutral Approach for a Healthier Lifestyle Among Obesity…Weight-Neutral Approach for a Healthier Lifestyle Among Obesity - A Lifestyle Intervention Anchored in SDOI

   Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Enrolling by Invitation

   Esbjerg Hospital - University Hospital of Southern Denmark·Not applicable· NCT05708417· Registry history of NCT05708417 on ClinicalTrials.gov (opens the registry)

   Changed Oct 4, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.